Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Medicamen Biotech
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.53 % | 8.49 % | 18.49 % |
|
5yr average Equity Multiplier
|
3.02 | 1.47 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.58 | 0.88 |
|
5yr Avg Net Profit Margin
|
2.89 % | 10.0 % | 18.1 % |
|
Price to Book
|
3.49 | 2.26 | 3.0 |
|
P/E
|
21.09 | 50.58 | 15.91 |
|
5yr Avg Cash Conversion Cycle
|
137.13 Days | 13.14 Days | -32.02 Days |
|
Inventory Days
|
140.46 Days | 66.66 Days | 24.72 Days |
|
Days Receivable
|
52.11 Days | 122.66 Days | 48.38 Days |
|
Days Payable
|
131.93 Days | 257.34 Days | 82.6 Days |
|
5yr Average Interest Coverage Ratio
|
2.31 | 10.36 | 87.2 |
|
5yr Avg ROCE
|
16.75 % | 12.12 % | 24.44 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 16.84 % | 22.46 % |
|
5 yr average Debt to Equity
|
0.86 | 0.14 | 0.02 |
|
5yr CAGR Net Profit
|
52.4 % | -6.51 % | 14.21 % |
|
5yr Average Return on Assets
|
3.05 % | 5.75 % | 15.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.93 % | 40.46 % | 46.67 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.11 % | -3.14 % | 0.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Medicamen Biotech
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|